Logo

Bio-Techne

Bio-Techne Q4 Revenues Jump 47 Percent

The firm's Diagnostics and Genomics revenues rose 38 percent to $67.1 million for the fourth quarter and rose 23 percent to $227.7 million for fiscal 2021.

Bio-Techne, Indian Eye Hospital Collaborate On Diagnostic Test for Ophthalmic Disorders

Eye hospital Narayana Nethralaya plans to conduct clinical trials and file for regulatory approval in India for a Bio-Techne test to detect ophthalmic disorders.

Bio-Techne Fiscal Q3 Revenues Rise 25 Percent as End Markets Improve

Its ProteinSimple proteomic analytical tools and Advanced Cell Diagnostics tissue biopsy products were standouts in the quarter, Bio-Techne's CEO said.

In Brief This Week: Bio-Techne, Mologic, Caris Life Sciences, And More

News items for the in vitro diagnostics industry for the week of April 5, 2021.

Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test

The firm said it will begin running its urine-based test immediately in its clinical laboratory in Munich and make it available throughout Europe.

Mar 19, 2021

In Brief This Week: Grail, Illumina, Veracyte, Aspira Women's Health, and More

Mar 17, 2021

Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy
Premium

Mar 3, 2021

Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

Mar 1, 2021

Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test

Feb 25, 2021

In Brief This Week: Thermo Fisher, BioReference Laboratories, Hologic, Invitae, Danaher, and More

Feb 9, 2021

Kantaro Biosciences, Atrys Health Partner to Distribute SARS-CoV-2 Antibody Tests

Feb 4, 2021

In Brief This Week: Quidel, Ortho Clinical Diagnostics, Hologic, Guardant Health, and More

Feb 2, 2021

Bio-Techne Fiscal Q2 Revenues Rise 21 Percent

Jan 14, 2021

JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More

Dec 2, 2020

Bio-Techne, Regulus Therapeutics to Develop Assays for Kidney Disease Treatment

Nov 25, 2020

Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Nov 5, 2020

Bio-Techne Fiscal Q1 Revenues Rise 11 Percent on Diagnostics and Genomics Sales

Oct 28, 2020

Kantaro Biosciences, EKF Diagnostics Ink European Distribution Deal for SARS-CoV-2 Antibody Tests

Oct 26, 2020

Kantaro Biosciences Gets CE Mark for Quantitative SARS-CoV-2 Antibody Test Kits

Sep 17, 2020

Bio-Techne, Qiagen Expand Partnership on Exosome Technology

Aug 24, 2020

Inflammatory Cytokine Biomarkers Predict COVID-19 Survival, Could Yield Dx, Rx Targets

Aug 4, 2020

Bio-Techne Q4 Revenues Drop 8 Percent

Jun 17, 2020

U of Kansas Inkjet Printing Approach Aims to Speed Development of Exosome-Based Microfluidic Tests

Jun 11, 2020

In Brief This Week: Hologic, Quidel, Illumina, Guardant Health, and More

May 26, 2020

Bio-Techne, Leica Biosystems Receive CE Mark for Pathology Detection Kit, Platform